comprehensive -WSS

comprehensive

author：knowledge 2025-08-04 03:40:07 - browse：46848

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Late stage cancers on the rise after pandemic delayed screenings

leisure time

knowledge

WSS

H.R. 3 is the wrong path to lower drug costs

FDA scientists endorse Pfizer/BioNTech Covid

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Scientific mystery highlights the blind spots in genomics databases

H.R. 3 is the wrong path to lower drug costs

A controversial new treatment promises to make little people taller

entertainment

comprehensive

focus

Psychedelics group wrestles with new pharma identity

Bird flu reported in person exposed to presumably infected cattle

Walensky prepares to leave CDC — and Congress — behind

Scientists uncover potential path to treating deadly childhood tumor

How one medical school became remarkably diverse

A controversial new treatment promises to make little people taller

Moonlake's readout produced a cash windfall. Risks remain

Trial using CRISPR to edit HIV out of cells disappoints

Heart attack and stroke risk calculators need revising

Alnylam reports growth in sales of rare disease treatments

Wikipedia

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Late stage cancers on the rise after pandemic delayed screenings

Hundreds died while taking an arthritis drug, but nobody alerted patients

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Researchers test human milk's ability to repair gut microbiome

Scientists uncover potential path to treating deadly childhood tumor

knowledge

leisure time

knowledge

hotspot